Express Scripts (ESRX) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
Express Scripts Announces 3rd Quarter Results; Increases 2015 Guidance Range
October 27, 2015 4:01 PM EDTST. LOUIS, Oct. 27, 2015 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2015 third quarter net income attributable to Express Scripts stockholders of $661.7 million, or $0.97 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, were $1.45 for the third quarter. 1
"With the rising cost of prescription drugs, we are continuing our mission to make medicine more affordable and accessible for clients and patients," said George Paz, Chairman and CEO. Â "Our innovative solutions, focused scale, specialized care and unmatched leadership manages cost more favorably for payers while improving health outcomes of... More
